| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/26/2001 | US6251603 Evaluating cancer in humans; detect preferential gene expression in tumor, mix sample with antibodies which bind preferential protein, count amount of protein, an amplified protein value indicates adjustment in cancer classification |
| 06/26/2001 | US6251601 Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays |
| 06/26/2001 | US6251588 Monitoring preferential nucleotide hybridization to target nucleotide sequence; generate nucleotide sequence of preferential size, incubate with target nucleotide sequences and monitor hybridization |
| 06/26/2001 | US6251587 Evaluating humans diagnosed with nervous system disorders; diagnose human with defect, determine genotype or phenotype of human, classify nervous system disorders |
| 06/26/2001 | US6251586 Epithelial protein and DNA thereof for use in early cancer detection |
| 06/26/2001 | US6251585 Assay and reagents for identifying anti-proliferative agents |
| 06/26/2001 | US6251584 Specific binding assays using methyl orange |
| 06/26/2001 | US6251582 Alternative G-coupled receptors associated with retroviral entry into cells, methods of identifying the same, and diagnostic and therapeutic uses thereof |
| 06/26/2001 | US6251581 Mixture of suspendable particles, one type is chemiluminescent compound capable of reacting with singlet oxygen, the other type is photosensitizer which is capable of activating oxygen to its singlet state |
| 06/26/2001 | US6251516 Isolation of cellular material under microscopic visualization |
| 06/26/2001 | US6251467 Isolation of cellular material under microscopic visualization |
| 06/26/2001 | US6251406 Attenuated microorganism strains and their uses |
| 06/26/2001 | US6251404 Collecting a sample of a naturally occurring isolated virus such as the iowa strain, and a naturally occuring strain that causes lesions in colostrum deprived piglets, treating to deactivate virus and admixing with carrier |
| 06/26/2001 | US6251399 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 06/26/2001 | US6251397 Purified polypeptides encoded by open reading frames (orf's) of a highly virulent strain of the virus as determined by its ability to induce lung lesions in 51.9% of colostrum-deprived piglets; vaccines |
| 06/26/2001 | US6251395 Inhibiting macrophage infiltration at the site of a central nervous system injury such as spinal cord injury by administering an anti-integrin subunit alpha-d monoclonal antibody |
| 06/26/2001 | US6251393 Conformation-specific anti-von Willebrand Factor antibodies |
| 06/26/2001 | US6251389 Human nucleotide pyrophosphohydrolase-2 |
| 06/26/2001 | US6251387 Topoisomerase I |
| 06/26/2001 | US6251384 Metastasis models using green fluorescent protein (GFP) as a marker |
| 06/26/2001 | US6251303 Water-soluble fluorescent nanocrystals |
| 06/26/2001 | US6251278 Process for separating a substance from a mixture |
| 06/26/2001 | US6251245 Detecting and analyzing apparatus for positive ions and negative ions in a liquid |
| 06/26/2001 | US6250152 Sensor arrangement |
| 06/26/2001 | US6250147 Device and method for analyzing starch-containing product |
| 06/26/2001 | US6250138 Determining fluid bubble point pressure using an adjustable choke |
| 06/26/2001 | US6250137 Method and apparatus for determining gasoline characteristics by using ultrasonic wave |
| 06/26/2001 | US6250136 Molten glass viscosity and/or level meter |
| 06/26/2001 | US6250133 Method for detecting venting of a combustion appliance within an improper space |
| 06/26/2001 | US6250132 Method and apparatus for real time gas analysis |
| 06/26/2001 | CA2245461C Detection of conditions or diseases associated with an altered level of telomerase activity |
| 06/23/2001 | CA2696661A1 Thermally conductive sensor |
| 06/23/2001 | CA2329487A1 Assay method |
| 06/23/2001 | CA2305067A1 Musical representation of gemstone signature |
| 06/23/2001 | CA2293082A1 Musical representation of diamond signature |
| 06/21/2001 | WO2001045122A1 Reagents, methods and kits for detecting bacillus thuringiensis proteins |
| 06/21/2001 | WO2001044819A2 Hematological assay and reagent |
| 06/21/2001 | WO2001044818A2 Method for determining parathormone activity in a human sample |
| 06/21/2001 | WO2001044817A2 Fluorescence correlation spectroscopy to identify compound-target binding |
| 06/21/2001 | WO2001044816A2 Conformational and topological protein regulation |
| 06/21/2001 | WO2001044815A1 Helicobacter pylori antigens in blood |
| 06/21/2001 | WO2001044814A1 Support having space-forming member |
| 06/21/2001 | WO2001044813A2 Use of wicking agent to eliminate wash steps for optical diffraction-based biosensors |
| 06/21/2001 | WO2001044812A1 Method for the simultaneous analysis and detection of multiple analytes by micro identification |
| 06/21/2001 | WO2001044811A2 Plasminogen activator assay involving an elastase inhibitor |
| 06/21/2001 | WO2001044810A1 Method for immunologically assyaing pivka-ii |
| 06/21/2001 | WO2001044809A2 Evaluation of biological agents in living target cells |
| 06/21/2001 | WO2001044808A2 Methods of diagnosis and treatment by binding p75/airm1 |
| 06/21/2001 | WO2001044807A1 METHOD OF SCREENING REMEDY FOR CANCER WITH THE USE OF INTERACTION DOMAINS OF p53 AND MORTALIN |
| 06/21/2001 | WO2001044806A1 Method of measuring etiology of disease caused by cytozoic pathogen and method of measuring etiology of kawasaki disease |
| 06/21/2001 | WO2001044805A2 Permeation layer attachment chemistry and method |
| 06/21/2001 | WO2001044802A1 Method for the determination of gaseous chemical components in a process reactor for treating electrical components, in particular wafers |
| 06/21/2001 | WO2001044789A1 Apparatus and methods for high throughput determination and ranking of formulations and solubility |
| 06/21/2001 | WO2001044787A1 Device for exposing a sample to electromagnetic radiation, for testing the aging of samples |
| 06/21/2001 | WO2001044784A1 Microwave unit and system for tissue processing |
| 06/21/2001 | WO2001044783A1 Rapid tissue processor |
| 06/21/2001 | WO2001044782A1 Device and method for taking a biological sample |
| 06/21/2001 | WO2001044779A2 Method of processing and testing powdered samples using immunochromatographic strip tests |
| 06/21/2001 | WO2001044516A2 Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated rna decay |
| 06/21/2001 | WO2001044515A2 Apparatus for performing biological reactions |
| 06/21/2001 | WO2001044511A2 Methods and compositions for detection of mycobacterium avium complex species |
| 06/21/2001 | WO2001044510A2 Nucleic acid amplification and detection of mycobacterium species |
| 06/21/2001 | WO2001044508A2 Method to evaluate the sensitivity of hiv variants to drugs able to inhibit the hiv protease |
| 06/21/2001 | WO2001044503A1 Biochips, preparation and uses |
| 06/21/2001 | WO2001044501A2 Method and device for detecting and quantifying biomolecules |
| 06/21/2001 | WO2001044500A2 Method and device for fluid quality measurement |
| 06/21/2001 | WO2001044499A1 Modified labeled complement components for immunoassays |
| 06/21/2001 | WO2001044497A2 Protein kinase regulation |
| 06/21/2001 | WO2001044496A2 Protease-activated receptor (par) modulator assays |
| 06/21/2001 | WO2001044493A2 Hematological assay and reagent |
| 06/21/2001 | WO2001044474A1 2871 receptor, a g-protein coupled receptor and methods of use thereof |
| 06/21/2001 | WO2001044473A2 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044470A1 Novel human rna helicase, helicain |
| 06/21/2001 | WO2001044467A2 Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulators |
| 06/21/2001 | WO2001044463A1 Shotgun scanning, a combinatorial method for mapping functional protein epitopes |
| 06/21/2001 | WO2001044448A2 Human oxidoreductase proteins |
| 06/21/2001 | WO2001044445A2 Human lyases and associated proteins |
| 06/21/2001 | WO2001044441A1 Stabilizing diluent for polypeptides and antigens |
| 06/21/2001 | WO2001044439A2 Glucocorticoid induced receptor (hgir,rp-23) ligand screening |
| 06/21/2001 | WO2001044438A2 Serological diagnostic method with rickettsia pulicis bacterium |
| 06/21/2001 | WO2001044301A1 Immobilized single domain antigen-binding molecules |
| 06/21/2001 | WO2001044298A1 Improvement of therapeutic potential of immunoglobulin preparations |
| 06/21/2001 | WO2001044292A2 Wasp (wiskott-aldrich syndrome protein) family protein fragments, and use thereof |
| 06/21/2001 | WO2001044291A2 Polynucleotid encoding the rg1 polypeptide |
| 06/21/2001 | WO2001044286A2 Five-helix protein |
| 06/21/2001 | WO2001044282A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/21/2001 | WO2001044280A2 Methods and compositions for the manufacture of replication incompetent adenovirus |
| 06/21/2001 | WO2001044269A2 Brain protein markers |
| 06/21/2001 | WO2001044266A2 Nucleic acid compounds and screening assays using the same |
| 06/21/2001 | WO2001044205A2 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents |
| 06/21/2001 | WO2001043876A1 Devices and methods for making bioarrays |
| 06/21/2001 | WO2001043875A1 Flow cell array and the utilization thereof for multianalyte determination |
| 06/21/2001 | WO2001043870A2 Column and row addressable high density biochip array |
| 06/21/2001 | WO2001043869A2 Cell arrays and the uses thereof |
| 06/21/2001 | WO2001043836A1 Golf ball support with a body axis that is excentric towards the rear |
| 06/21/2001 | WO2001043767A1 Phosphoglycerate kinase in the treatment of disease |
| 06/21/2001 | WO2001043763A1 Betaglycan as an inhibin receptor and uses thereof |
| 06/21/2001 | WO2001043738A1 Method for detecting nucleotide synthesis inhibitors having fewer side effects |
| 06/21/2001 | WO2001043691A2 Fragments and antagonists of heat shock protein 60 |